Delivery Order 75N92019D00017-75N92023F00001
Award Date
9/25/23
Potential Completion Date
6/30/24
Potential Value
$234K
Federal Agency
National Heart Lung and Blood Institute
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost Plus Fixed Fee
Place of Performance
Albuquerque, NM 87108, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to the Lovelace Biomedical Research Institute. The $1,143,792.16 cost-plus-fixed-fee contract is for the GENE THERAPY RESOURCE PROGRAM (GTRP) and calls for the awardee to provide a Pharmacology and Toxicology Core Laboratory. The contract does not have a set-aside designation. Lovelace Biomedical Research Institute is a not-for-profit...
This is a federal contract award to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization, by the National Heart Lung and Blood Institute (NHLBI). The $1,609,194.07 contract is a Delivery Order under the Gene Therapy Resource Program (GTRP) to provide pharmacology/toxicology core laboratory services for a scientific project. This work supports the National Institutes of Health's research efforts in gene therapy. The contract does not have a set-aside...
This is a $507,702.77 cost-plus-fixed-fee delivery order contract awarded by the National Heart, Lung, and Blood Institute (NHLBI) to the Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract supports the NHLBI's Gene Therapy Resource Program (GTRP) by providing resources and services from three core laboratories focused on pharmacology and toxicology, preclinical vector development, and a clinical coordinating center. This contract...
This is a cost-plus-fixed-fee delivery order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The $625,343.90 contract is for the PHARMACOLOGY/TOXICOLOGY CORE LABORATORY PROJECT under the Gene Therapy Resource Program (GTRP). Lovelace will provide a range of preclinical research services to support the...
This is a delivery order under the Gene Therapy Resource Program (GTRP) contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The GTRP contract provides pharmacology and toxicology core laboratory services to support gene therapy research and development. The $10,766 delivery order was awarded to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. Lovelace will provide...
This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of Lovelace Biomedical Research Institute. The $203,807.96 contract is a delivery order for Task Area A under the Pharmacology-Toxicology Core Lab task order 7 of the NHLBI's Gene Therapy Resource Program (GTRP). The work, which has no set-aside designation,...
This is a cost-plus-fixed-fee task order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Heart Lung and Blood Institute to Lovelace Biomedical Research Institute, a not-for-profit contract research organization. The $352,485.43 task order is for pharmacology/toxicology core laboratory services in support of the Gene Therapy Research Program (GTRP). It does not have a set-aside designation. Lovelace Biomedical has a history of serving as a...
This is a federal contract award issued by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI), a subsidiary of Lovelace Biomedical Research Institute. The $1,013,722.26 award is for Task Order 6, Task Area B under the GTRP Pharmacology-Toxicology Core Lab contract. The work will be performed in Albuquerque, NM and the period of performance runs through April 15,...
This is a federal contract award from the National Heart Lung and Blood Institute (NHLBI), a civilian agency under the Department of Health and Human Services, to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI) for the "Gene Therapy Resource Program (GTRP), Pharmacology-Toxicology Core Lab." The contract is a $1,748,740.00 cost-plus-fixed-fee delivery order with a period of performance through July 31, 2017. LBERI, a non-profit organization doing business as...
This is a federal contract award to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization, by the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). The $366,923 cost-plus-fixed-fee contract is for the efficacy and safety evaluation of a lead gene therapy candidate in methyl malonic acidemia (MMAB) disease mouse models, as well as the development of bioanalytical assay methods. The...